INVO Bioscience Inc.

NASDAQ: INVO · Real-Time Price · USD
0.83
-0.02 (-2.35%)
At close: Oct 21, 2024, 10:00 PM

INVO Bioscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.64B 6.53B 1.43M 1.84M 1.58M 1.38M 974.89K 315.9K 348.02K 278.14K 235.32K 146.13K 162.6K 3.05M 218.87K 208.47K 684.52K
Cost of Revenue
1.04B 3.65B 988.47K 861.65K 1.08M 886.75K 580.97K 255.42K 72.55K 79.19K 109.12K 192.61K 64.96K 47.29K 20.42K 14.6K 62.74K
Gross Profit
592.26M 2.87B 444.69K 744.61K 499.09K 495K 393.93K 60.48K 275.47K 198.95K 126.2K -46.47K 97.64K 3M 198.46K 193.88K 621.78K
Operating Income
-17.11B -8.12B -1.3M -1.9M -946.37K -1.51M -886.29K -2.07M -2.31M -2.72M -2.53M -2.68M -2.7M 503.56K -2.27M -1.89M -1.56M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 34.00 48.00 225.00 62.00 n/a 2.42K 2.01K
Pretax Income
-17.4B -9.11B -1.6M -2.25M -1.59M -1.97M -1.25M -2.24M -2.55M -2.76M -2.55M -2.8M -2.77M 101.78K -2.48M -1.82M -2.45M
Net Income
-17.4B -9.34B -1.63M -2.25M -1.6M -1.99M -1.25M -2.24M -3.01M -2.77M -2.57M -2.8M -2.85M -141.53K -2.24M -1.82M -2.45M
Selling & General & Admin
2.55B 9.07B 1.51M 2.65M 1.44M 1.86M 1.26M 2.04M 2.51M 2.84M 2.48M 2.44M 2.69M 2.43M 2.42M 2.05M 2.12M
Research & Development
265.66M 489.66M n/a n/a 4.88K 5.91K 2.67K 83.85K 73.52K 73.83K 175.27K 190.76K 104.18K 63.76K 55.39K 31.02K 66.27K
Other Expenses
14.88B 1.43B 230.5K 230.34K n/a 180.39K 20.5K 19.71K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
17.7B 10.99B 1.75M 2.65M 1.45M 2M 1.28M 2.13M 2.58M 2.92M 2.65M 2.64M 2.8M 2.5M 2.47M 2.08M 2.18M
Interest Expense
-311.27M -1.06B 273.63K 369.61K 181.29K 182.04K 352.08K 175.19K 216.59K 56.13K 1.76K 102.00 1.46K 186.46K 93.39K 91.13K 895.23K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
18.74B 14.65B 2.73M 3.74M 2.52M 2.89M 1.86M 2.38M 2.65M 3M 2.76M 2.83M 2.86M 2.54M 2.49M 2.1M 2.24M
Income Tax Expense
n/a -22.94M 29.26K n/a 1.84K 23.04K 1.89K 2.87K 461.05K 2.07K 24.2K 800.00 73.37K 4.76K n/a n/a n/a
Shares Outstanding (Basic)
138.91K 3.1M 3.89M 3.61M 3.8M 1.57M 1.78M 732.25K 622.5K 608.41K 607.78K 605.76K 602.53K 523.2K 523.2K 522.21K 494.4K
Shares Outstanding (Diluted)
138.91K 3.1M 3.89M 3.61M 3.8M 1.57M 1.78M 732.25K 622.5K 608.41K 607.78K 605.76K 602.53K 523.2K 523.2K 522.21K 494.4K
EPS (Basic)
-125.28K -3.02K -0.42 -0.62 -0.42 -1.27 -0.7 -3.06 -4.84 -4.55 -4.23 -4.62 -4.73 -0.27 -4.29 -3.48 -4.96
EPS (Diluted)
-125.28K -3.02K -0.42 -0.62 -0.42 -1.27 -0.7 -3.06 -4.84 -4.55 -4.23 -4.62 -4.73 -0.27 -4.29 -3.48 -4.96
EBITDA
-16.87B -9.5B -1.1M -1.65M -1.19M -1.65M -873.97K -2.04M -2.31M -2.63M -2.53M -2.72M -2.7M 507.63K -2.36M -1.69M -1.55M
EBIT
-17.11B 4.62M -1.33M -1.88M -1.41M -1.79M -894.47K -2.06M -2.33M -2.71M -2.55M -2.8M -2.77M 503.56K -2.39M -1.73M -1.56M
Depreciation & Amortization
234.46M 918.92M 230.5K 230.34K 226.96K 141.6K 20.5K 19.7K 76.95K 77.55K 77.1K 79.22K 72.45K 79.36K 31.58K 31.56K 8.56K